The US Patent & Trade Office on March 7, 2013 granted GW Pharma a - TopicsExpress



          

The US Patent & Trade Office on March 7, 2013 granted GW Pharma a medical patent covering all plant-based phytocannabinoids for use in the treatment and prevention of basically all forms of human cancer. From Cannabis and Cannabinoids (PDQ®) Last Modified: 01/17/2013 “Cannabinoids may cause antitumor effects by various mechanisms, including induction of cell death, inhibition of cell growth, and inhibition of tumor angiogenesis invasion and metastasis.” “One review summarizes the molecular mechanisms of action of cannabinoids as antitumor agents. Cannabinoids appear to kill tumor cells but do not affect their non-transformed counterparts and may even protect them from cell death.” “These compounds have been shown to induce apoptosis in glioma cells (a type of brain cancer) in culture and induce regression of glioma tumors in mice and rats. Cannabinoids protect normal glial cells of astroglial and oligodendroglial lineages from apoptosis mediated by the CB1 receptor.”
Posted on: Thu, 06 Jun 2013 23:08:05 +0000

Trending Topics



Recently Viewed Topics




© 2015